Meagan Jacoby is an Oncology physician affiliated with Barnes-Jewish Hospital. OpenAlex indexes 171 publications with 4,357 citations (h-index 29); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4500 Forest Park Ave
Div Im Bone Marrow Transplant, 5th, 6th, 8th Fl
Saint Louis, MO 631082114
Telephone
314-454-8304Registry record last updated 17 Apr 2025.
Clinical trials
- Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
Sponsor: Washington University School of Medicine
- Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
Sponsor: Washington University School of Medicine
- Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
Sponsor: Washington University School of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20252 payments
- Gilead Sciences, Inc.Program year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
35.1%Corticosteroid29.1%Dexamethasone sodium phosphate94%Hydrocortisone6%Part D + Part B<11 patientsFluoroquinolone Antibacterial5.9%Ciprofloxacin Hcl100%Part D≥21 patientsAnti-infectives
17.8%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor5.7%Valacyclovir100%Part D≥17 patientsAzole Antifungal4.3%Fluconazole100%Part D<11 patients+ 2 more classes in this area
Dermatology
10.6%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor10.6%Acyclovir100%Part D≥32 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2024–2026 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025
Journal of the National Comprehensive Cancer Network
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Tsuyoshi Kaneko, MD
Barnes-Jewish Hospital
Sidharth Puram, MD
Barnes-Jewish Hospital
Iskra Pusic, MD
Barnes-Jewish Hospital
Laura Schuettpelz, MD
Barnes-Jewish Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”